Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00325806
Status:
COMPLETED
Last Update Posted:
2013-03-08
First Post:
2006-04-11
Brief Title:
Ramipril - Hypertension
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Prevention of Hypertension in Patients With High-Normal Blood Pressure With the Angiotensin-Converting-Enzyme-Inhibitor Ramipril - a Randomised Prevention Trial of the German Hypertension League
Status:
COMPLETED
Status Verified Date:
2013-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Primary objective
Mean values of systolic and diastolic office blood pressure
Secondary objectives
Total mortality occurrence of cardio- and cerebrovascular events change of mean blood pressure ABPM Ambulatory Blood Pressure Monitoring during the observation
Mean values of systolic and diastolic office blood pressure
Secondary objectives
Total mortality occurrence of cardio- and cerebrovascular events change of mean blood pressure ABPM Ambulatory Blood Pressure Monitoring during the observation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None